This week from Drug Target Review...
EDITOR'S PICK
Stopping immune cell leakage from tumours could improve skin cancer treatment
Results show the number of specialised immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumours.
Researchers at NYU Langone Health and its Perlmutter Cancer Center, both US, who led the study found that combining a chemical blocker of immune cell exit with another drug type, an immunotherapy, stopped melanoma tumour enlargement in more than half of mice tested. Immunotherapy alone had previously failed to prevent the cancers’ growth. Read more>>>
===
TRENDING THIS WEEK
New hydrogel stem cell treatment could repair injured brain tissue
The new ‘hybrid’ hydrogel allowed researchers to safely deliver stem cells to the site of a brain injury in mice. Read more>>>
Could long Covid be solved by autoantibodies?
Swiss researchers have found a new class of ‘good autoantibodies’, which are associated with a favourable course and lower risk of long-Covid. Read more>>>
National Glaucoma Week
Scientists discover therapeutic target that could treat glaucoma
The researchers found restoring mitochondrial homeostasis in the diseased neurons could protect the optic nerve cells from being damaged from glaucoma. Read more>>>
3D map reveals DNA organisation within human retina cells
Scientists shed light on how genetic architecture in human retina cells determine gene expression, tissue-specific function, and disease phenotype in blinding diseases. Read more>>>
===
WHAT TO LISTEN TO
Our podcasts are designed with researchers and scientific leaders in mind. We sit down with industry experts and dive into the latest trends, research and innovation in drug discovery and early-phase therapeutic development.
Listen to our latest episodes discussing topics such as multiplexed imaging, complex assays and organoids.
- Episode 13 – Multiplexing
- Episode 14 – Complex assays
- Episode 15 – Minimise variability issues in your organoids
All caught up? Follow us on Spotify, Apple and Google Podcasts to get notified when our next episode is live!
===
WHAT TO WATCH
Discover our range of upcoming live webinars and on-demand sessions which are completely FREE to join.
===
JOIN THE COMMUNITY
Get your FREE subscription to Drug Target Review to stay up to date with the most pressing topics and trends in drug discovery and early-phase therapeutic development.
Cut down on screen time by listening to our podcasts, get intimate during our webinars or sip a cup of coffee whilst flicking through our journal. As a member, you’ll also gain exclusive access to:
- Breaking news and features
- Invitations to member only events
- Unlimited archive of whitepapers, ebooks, past issues and much more…
We provide compelling content contributed by the world's most respected scientists, key opinion leaders and influencers.
Want to keep up to date with our latest content? Follow us on LinkedIn, Facebook, Twitter and YouTube.
